Code | 4119E | ||||||||||
MA number | EU/1/08/494/007 | ||||||||||
Product Form: | sol inj 1x1 ml/90 mg (pero inj.napl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Janssen - Cilag International N.V., Belgium | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 16.01.2009 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 20.07.2023 |